Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

35 results about "Abdominal obesity" patented technology

Abdominal obesity, also known as central obesity, occurs when excessive abdominal fat around the stomach and abdomen has built up to the extent that it is likely to have a negative impact on health. Central obesity has been strongly linked to cardiovascular disease, Alzheimer's disease, and other metabolic and vascular diseases.

Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereof

The present invention is directed to a System characterization of NASH that combines Modeling and Biomarkers, enabling pharmaceutical compositions and methods of treatment that relate to the inhibition, resolution and / or prevention of Non Alcoholic Fatty Liver Disease (NAFLD) and Non Alcoholic Steatohepatitis (NASH). Said conditions are Liver related complications among the array of manifestations of metabolic syndromes, including Type 2 diabetes, hyperlipidemia, weight gain, abdominal obesity, insulin resistance, hypertension, atherosclerosis, fatty liver diseases and certain chronic inflammatory states that lead to these manifestations, among others. In additional aspects, the present invention relates to compositions and methods which may be used to treat, inhibit or reduce the likelihood of NASH and NAFLD complications in patients with hepatitis viral infections, including Hepatitis B and Hepatitis C viral infections, as well as the secondary disease states and / or conditions which are often associated with such viral infections, including hepatic steatosis (steatohepatitis), cirrhosis, fatty liver and hepatocellular cancer, metabolic syndrome complications including cardiovascular diseases, neurodegenerative diseases and premature ageing, among other disease states or conditions.
Owner:APHAIA PHARMA AG +1

Pyrazole compound as well as composition and application thereof

The invention provides a compound and application of the compound and the pharmaceutically acceptable salt thereof or a stereo isomer or a prodrug molecule thereof in preparing a medicament for treating or preventing metabolic diseases, wherein the compound has the structural characteristic of a general expression I and is used as a novel fat cell type fatty acid binding protein FABP inhibitor. The compound having the structural characteristic of the general expression I can provide a new selection for the clinical prevention and treatment of the following diseases: 1. type II diabetes, 2. hyperglycemia, 3. hypoglycemia tolerance, 4. insulin resistance, 5. adiposity, 6. lipid turbulence, 7. blood-lipoid imbalance, 8. hyperlipaemia, 9. hypertriglyceridemia, 10. hypercholesterolemia, 11. low high-density protein level, 12. overhigh low-density protein level, 13. atherosclerosis and secondary diseases thereof, 14. hemadostenosis, 15. abdominal obesity, 16. a metabolic syndrome and 17. fatty liver.
Owner:GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI

Weight losing medicine composition, preparation containing medicine composition and preparation method of medicine composition

The invention relates to a weight losing medicine composition, a preparation containing the medicine composition and a preparation method of the medicine composition, belonging to the technical field of medicines. The weight losing medicine composition comprises the following active ingredients: Indian buead, largehead atractylodes rhizome, pinellia tuber, immature bitter orange, fortune eupatorium herb, rhizoma atractylodis, officinal magnolia bark, rhubarb, radix bupleuri, katsumade galangal seed, lotus leaf, combined spicebush root, cassia bark, safflower, Chinese angelica, white paeony root, Szechuan lovage rhizome, pericarpium zanthoxyli, radix astragali, oriental waterplantain rhizome, villous amomum fruit and capsaicine. A new way is provided for treating obesity, especially abdominal obesity. The weight losing medicine composition and the preparation containing the medicine composition can be used for resolving turbidity and eliminating fullness and preventing and treating complications of obesity, especially abdominal obesity by improving fat metabolism and have the effect of obviously improving abdominal fat accumulation. In particular, the smearing preparation can be locally used and combines with cupping therapy to promote medicine absorption and prolong the duration of the curative effects, and can be used for clinically preventing and treating abdominal obesity and complications thereof.
Owner:DONGFANG HOSPITAL BEIJING UNIV OF CHINESE MEDICINE

Belly massager

The invention relates to the field of health care and beauty products and medical instruments, in particular to a belly massager suitable for gastrointestinal motility insufficient patients and abdominal obesity patients. The belly massager can be manufactured in three types which are the single-disc belly massager, the four-disc belly massager and the two-disc belly massager. According to the single-disc belly massager, a motor is connected with a massage shaft component and a massage head component through an eccentric coupler and drive the massage shaft component and the massage head component to rotate, so that a bottom massage disc conducts parallel circular motion, and the belly of a patient is massaged. The four-disc belly massager and the two-disc belly massager are each provided with two gear motors, each motor drives two sets of massage shaft components and massage head components to rotate through a driving gear and a driven gear, and multiple portion massage is achieved. The massage head components can be rapidly detached and installed, and massage heads are convenient to replace. The belly massager is small in size and weight and can be held by hands or tightened through a pull belt to conduct massage, a user operates the belly massager conveniently and freely, and the belly massager has the relatively high use comfort level and massage efficiency.
Owner:杨昕

Health care alga agar-agar jelly and preparation method of health care alga agar-agar jelly

The invention discloses health care alga agar-agar jelly, which is prepared from the following ingredients in percentage by mass: 1 to 3 percent of dry agar, 10 to 15 percent of fresh caulerpa lentillifera, 5 to 8 percent of traditional Chinese medicine extraction liquid, 0.1 to 0.3 percent of white vinegar and the balance pure water; the traditional Chinese medicine extraction liquid is prepared from the following ingredients in parts by weight: 8 to 10 parts of semen cassiae, 6 to 8 parts of tuckahoe, 10 to 15 parts of rose, 8 to 12 parts of roselle, 6 to 8 parts of Laoshan green tea, 6 to 8 parts of bananas, 10 to 15 parts of strawberries, 15 to 20 parts of smallanthus, 10 to 12 parts of mulberry leaves, 8 to 10 parts of honey-fried licorice roots and 8 to 12 parts of water chestnut. The health care alga agar-agar jelly can be used for treating and preventing abdominal obesity by using methods of soothing the liver and regulating the circulation of qi, clearing the bowels to facilitate feces excretion, and stabilizing and lowering the blood pressure; in addition, the taste is fragrant, sweet and delicious; no obvious alga fishy smell or traditional Chinese medicine bitter taste exists; the weight losing effect can be achieved after the eating for a long time.
Owner:QINGDAO HAIZHIYUAN INTELLIGENT TECH

Health food and its preparation method

The invention discloses a health food for reducing weight, reducing blood pressure, reducing blood-lipid and reducing blood sugar, and a preparation method thereof. The inventive health food comprises, based on the weight part, 5 to 40 parts of black fungus, 5 to 10 parts of konjak and 1 to 6 parts of tuckahoe. On the basis that the natural flavor, colour and nutrient content of black fungus are retained, the preparation combines the traditional dietary cure health preserving formulation with the modern biotechnology, and makes the best of the unique bidirectional adjusting technic in Chinesemedicine. After people orally take the black fungus beverage and black fungus capsule prepared by the invention, the metabolite in the cardiovascular system and gastrointestinal tract system of the body can be cleaned up, the endocrine system can be adjusted, and the stable ability of the inner environment of body can be enhanced, and the nutritional and metabolic disease can be prevented. The black fungus beverage and black fungus capsule prepared by the invention have the special effect for the prevention and auxiliary treatment of the metabolic chronic disease such as insulin resistance and the like, especially for abdominal obesity.
Owner:湖北千之鹤黑木耳食品有限公司

Chair back with abdomen rest

The present invention is one kind of chair, which has one inclined seat with lower front part and higher back part, and one abdomen rest connected to the seat, the pedestal, the tray or the arm rest to support the abdomen. The chair with abdomen rest makes the person in the chair in excellent physiological state, and can remit fatigue and inhibit abdominal obesity. The present invention is especially suitable for staff, student and computer operator.
Owner:李福德

Automatic massage apparatus for gastrointestinal diseases or abdominal obesity

The invention relates to the technical field of massage, and discloses automatic massage apparatus for gastrointestinal diseases or abdominal obesity. The automatic massage apparatus comprises a mounting box, wherein the left and right sides of the mounting box are fixedly connected with waist belts, a position-limiting plate and a motor are respectively arranged inside the mounting box, the edgeof the position-limiting plate is fixedly connected with slide rails, an output end of the motor is movably connected with a central gear, the tooth edge of the central gear is in mesh connection withtransmission gears, the surface of each transmission gear is fixedly connected with a driving wheel, and the wheel edge of each driving wheel is movably connected with one end of a corresponding transmission belt. According to the automatic massage apparatus for gastrointestinal diseases or abdominal obesity, the central gear is driven to rotate through the motor, position-limiting blocks are indirectly driven to squeeze a massage airbag in a reciprocating manner, the airbag is repeatedly contracted and expanded to massage the abdomen of a user, spring rods and the position-limiting plate arecooperatively arranged for buffering and position-limiting, the massage force is prevented from being too large or too small, and thereby the effect of automatically pressing the abdomen and stabilizing the massage force is achieved.
Owner:翁云芬

Traditional Chinese medicine composition for reducing body fat mass and treating abdominal obesity, and application of traditional Chinese medicine composition

InactiveCN107595954AReduce body fatImprove body fat distributionMetabolism disorderPlant ingredientsAbdominal obesityLeptin resistance
The invention relates to a traditional Chinese medicine composition for reducing body fat mass and treating abdominal obesity. The traditional Chinese medicine composition is prepared from the following crude drugs in parts by weight: 2-4 parts of rhizoma coptidis, 1-3 parts of radix scutellariae, 1-3 parts of rhizoma polygoni cuspidati, 1-3 parts of radix lithospermi, 1-3 parts of honeysuckle flower, 2-4 parts of rhizoma atractylodis and 1-3 parts of lotus leaf. The traditional Chinese medicine composition is only prepared from the seven medicines, thus being fewer in medicines, low in priceand simple to prepare; the traditional Chinese medicine composition can be used for treating the abdominal obesity and reducing the body fat mass as well as improving the body fat distribution of patients and relieving leptin resistance, and is a safe and effective fat-reducing medicine.
Owner:SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M

Application of ophiopogon polysaccharide extract in preparing foodstuff additives, health-care products or medicines with weight-reducing function

The invention discloses an application of an ophiopogon polysaccharide extract (with peak top molecular weight of 3000-6500) in preparing foodstuff additives, health-care products or medicines with a weight-reducing function. According to the invention, abdominal obesity mice models are used in experiments for inspecting the inhibiting effect of the ophiopogon polysaccharide extract upon obese mice weight increasing, and the weight-reducing function of the ophiopogon polysaccharide extract is evaluated. The embodiment of the invention and animal experiment results proof that the ophiopogon polysaccharide extract has a substantial weight-reducing function. Therefore, the ophiopogon polysaccharide extract can be used for preparing foodstuff additives, health-care products or medicines with the weight-reducing function.
Owner:SHANGHAI UNIV OF T C M

Application of ophiopogon polysaccharide extract in preparation of medicines with anti-inflammatory effect

The invention discloses application of an ophiopogon polysaccharide extract (having a peak tip molecular weight within a range of 3,000-6,500Da) in preparation of medicines or health foods with an anti-inflammatory effect. A an abdominal obesity mouse model is used for investigating an experiment of inhibiting the secretion of inflammatory factors and the mRNA expression level of tissue inflammatory factor in serum of mice by using the ophiopogon polysaccharide extract, so that the anti-inflammatory effect of the ophiopogon polysaccharide extract is evaluated; the embodiments and animal results thereof prove that the ophiopogon polysaccharide extract has the remarkable anti-inflammatory effect; therefore, the ophiopogon polysaccharide extract can be used for preparing the medicines or health foods which have the anti-inflammatory effect.
Owner:SHANGHAI UNIV OF T C M

17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators

Compounds of formula I are modulators of the androgen receptor (AR) acting in a tissue-selective manner. These compounds alone or in combination with other active agents are effective in enhancing debilitating muscle tone and treating conditions caused by androgen deficiency or ameliorated by androgen administration, including osteoporosis, osteopenia, glucocorticoid-induced bone Osteoporosis, periodontal disease, fractures, bone damage after bone reconstruction surgery, sarcopenia, frailty, aging skin, hypogonadism in men, postmenopausal syndrome in women, atherosclerosis, hypercholesterolemia, hyperlipidemia obesity, aplastic anemia and other hematopoietic disorders, inflammatory arthritis and joint repair, HIV-wasting, prostate cancer, benign prostatic hypertrophy (BPH), abdominal obesity, metabolic syndrome, type II diabetes, cancer cachexia, al Alzheimer's disease, muscular dystrophy, cognitive decline, sexual dysfunction, sleep apnea, depression, premature ovarian failure and autoimmune diseases.
Owner:MERCK & CO INC

Traditional Chinese medicine acupoint application formula for abdominal obesity as well as preparation method and application of traditional Chinese medicine acupoint application formula

The invention discloses a traditional Chinese medicine acupoint application formula for abdominal obesity as well as a preparation method and application of the traditional Chinese medicine acupoint application formula. The traditional Chinese medicine acupoint application formula is characterized by comprising the following components in parts by weight: 18-22 parts of rhizoma coptidis, 18-22 parts of radix et rhizoma rhei, 18-22 parts of radix scutellariae, 18-22 parts of cortex phellodendri, 18-22 parts of poria cocos, 18-22 parts of fructus aurantii immaturus, 18-22 parts of myrrh, 15-18 parts of radix phytolaccae and 8-12 parts of radix glycyrrhizae. The medicine disclosed by the invention has effects of promoting QI circulation, tonifying the spleen, clearing heat, promoting diuresis, dissolving turbidity and the like, and the traditional Chinese medicine acupoint application prepared from the medicine has a good curative effect on abdominal obesity. The medicine has an obvious effect after being applied to the acupoint for 7-14 days. Clinical observation shows that the effect is better when the acupoint application time is prolonged.
Owner:殷杰

Collagen peptide oral liquid and preparation method thereof

The invention belongs to the field of oral liquid preparation, and mainly relates to collagen peptide oral liquid and a preparation method thereof. Specifically, every 100 mL of the collagen peptide oral liquid comprises the following components in percentage by mass: 5 to 15 percent of collagen peptide, 15 to 20 percent of a sweetening agent, 0.1 to 0.3 percent of malic acid, 0.3 to 1 percent of rose pollen, 0.05 to 0.3 percent of aronia juice powder, 0.2 to 0.7 percent of pomegranate juice powder, 0.02 to 0.05 percent of a saffron crocus extract and 65 to 75 percent of water. The collagen peptide oral liquid is rich in flower fragrance, rich in sour and sweet taste, good in stability and long in shelf life, can remarkably improve measurement indexes and lipid conditions of women with abdominal obesity, and improves the sleep quality of women and relieves anxiety to a certain extent.
Owner:JIANGZHONG PHARMA

Traditional Chinese medicine composition for patients with syndrome of interior dampness-heat and abdominal obesity and preparation method of traditional Chinese medicine composition

The invention relates to traditional Chinese medicine composition for patients with syndrome of interior dampness-heat and abdominal obesity and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from raw materials in parts by weight as follows: 25-35 parts of poria cocos extract, 25-35 parts of rhodiola, 25-35 parts of folium nelumbinis, 25-35 parts of herba gynostemmae, 10-20 parts of rhizoma coptidis, 10-20 parts of bulbus fritillariae thunbergii, 10-20 parts of radix salviae miltiorrhizae, 10-20 parts of pericarpium citri reticulatae, 10-15 parts of rhizoma pinelliae preparatum, 5-15 parts of stir-baked caulis bambusae in taeniam with ginger juice, 5-15 parts of bile arisaema and 5-15 parts of fructus amomi. The traditional Chinese medicine composition can specifically induce diuresis, clear dampness, clear away heat and purge pathogenic fire and has functions of comprehensively conditioning qi and blood, tonifying the spleen and nourishing the stomach, and phlegm-dampness in the body is dispelled, so that the syndrome of interior dampness-heat and the abdominal obesity are treated fundamentally; and according to the preparation method, all that is required is to crush and mix the raw materials, the process is simple and controllable, and large-scale production is facilitated.
Owner:万红

Procyanidine-containing prebiotics and application thereof to obesity and metabolic syndrome medicines

The invention discloses procyanidine-containing prebiotics and application thereof to obesity and metabolic syndrome medicines. The prebiotics take procyanidine as the main active ingredient. Procyanidine can improve the obesity and metabolic syndromes through wholly or partially depending on intestinal flora regulation. The relationship between GSPE and intestinal flora, inflammation and metabolism is creatively established for the first time to testify that the metabolism improvement function of GSPE wholly or partially depends on the intestinal flora. GSPE can serve as a brand-new prebiotics to be used for improving the obesity and metabolic syndromes of hosts, particularly abdominal obesity and 2-type diabetes.
Owner:SHANGHAI INST FOR ENDOCRINE & METABOLIC DISEASES +1

belly massager

The invention relates to the field of health care and beauty products and medical instruments, in particular to a belly massager suitable for gastrointestinal motility insufficient patients and abdominal obesity patients. The belly massager can be manufactured in three types which are the single-disc belly massager, the four-disc belly massager and the two-disc belly massager. According to the single-disc belly massager, a motor is connected with a massage shaft component and a massage head component through an eccentric coupler and drive the massage shaft component and the massage head component to rotate, so that a bottom massage disc conducts parallel circular motion, and the belly of a patient is massaged. The four-disc belly massager and the two-disc belly massager are each provided with two gear motors, each motor drives two sets of massage shaft components and massage head components to rotate through a driving gear and a driven gear, and multiple portion massage is achieved. The massage head components can be rapidly detached and installed, and massage heads are convenient to replace. The belly massager is small in size and weight and can be held by hands or tightened through a pull belt to conduct massage, a user operates the belly massager conveniently and freely, and the belly massager has the relatively high use comfort level and massage efficiency.
Owner:杨昕

Traditional Chinese medicine composition for treating abdominal obesity and preparation and external preparation thereof

The invention discloses a traditional Chinese medicine composition for treating abdominal obesity and an external preparation. The traditional Chinese medicine composition comprises the following components in parts by weight: 1-3 parts of rheum officinale, 1-3 parts of kudzuvine root, 3-5 parts of divaricate saposhnikovia root, 3-5 parts of Chinese angelica, 0.5-1.5 parts of rhizomaalismatis, 0.5-1.5 parts of mint, 0.05-0.15 part of menthol, 0.01-0.03 part of divaricate saposhnikovia root volatile oil and 0.01-0.03 part of Chinese angelica volatile oil. The external preparation can achieve the purposes of directional weight reduction, fat reduction, strong transdermal absorption promotion and no side effect, can also be used for treating haemorrhoids, and is safe and reliable.
Owner:GUANGDONG PHARMA UNIV

Navel electrothermal powder, and application method and device thereof

PendingCN110269917AAvoid and reduce damageAvoid damageAntipyreticAnalgesicsApocynum venetumLicorice roots
The invention relates to the technical field of navel treatment, and discloses navel electrothermal powder, and an application method and device thereof. The navel electrothermal powder is mainly prepared by crushing of radix astragali, safflowers, rhizoma corydalis, rhizoma ligustici wallichii, apocynum venetum, common selfheal fruit-spike, caulis polygoni multiflori, platycodon roots, radix stemonae, common coltsfoot flower and licorice roots. The navel electrothermal powder disclosed by the invention can effectively prevent and treat abdominal obesity / central obesity and prevent and treat symptoms including flatulence, indigestion, lower abdomen cold pain, dysmenorrhea, menstrual period lumbago, cold hands and feet, limb drowsiness, fatigue and weakness, cough, asthma and the like caused by the abdominal obesity / central obesity, and has the characteristic of being free from infusion, free from injection, free from medicine taking, free from acupuncture and moxibustion, free from cupping, free from skin scraping therapy, and simple and convenient to operate; and besides, oral administration is not needed, so that damage of traditional Chinese medicines to the liver is avoided and reduced; trouble and discomfort in mouth feel caused by decocting medicines and taking medicines orally do not exist; the navel electrothermal powder can be repeatedly used, so that the medicine purchasing cost can be effectively reduced, time and temperature of hot compressing can be autonomously and easily controlled, and the operation is convenient, simple and practicable.
Owner:贾玉山

Method and device for the in vitro detection of polycystic ovarian syndrome (pcos) and pathologies involving cardiovascular risk

InactiveUS20090208928A1High sensitivityStatistical significance is improvedBioreactor/fermenter combinationsBiological substance pretreatmentsLow HDL-cholesterolCvd risk
The invention relates to a method and device for the in vitro detection of polycystic ovary syndrome (PCOS) and pathologies involving cardiovascular risk. An in vitro assay method and assay device (kit) for the diagnosis of the presence or the predisposition to suffer from PCOS and / or cardiovascular risk factors including: general obesity, abdominal obesity, hypertension, glucose intolerance, diabetes, hyperinsulinemia, general hypercholesterolemia, hypercholesterolemia with high LDL-cholesterol levels, low HDL-cholesterol levels and hypertriglyceridemia, as well as the grouping of some of these cardiovascular risk factors known as metabolic syndrome. The method and the kit are characterized in that they are based on the detection of at least one genotype or haplotype of a polymorphism in the CAPN5 gene selected from: Nt g.86 A>G, Nt g.344 G>A, Nt c.1320 C>T and Nt c.1469 G>A or combinations thereof.
Owner:NEOCODEX

Injection for treating premature ovarian failure

The invention relates to the technical field of medicines, in particular to injection for treating premature ovarian failure. The injection comprises 50 to 200 milligrams of flavone, 10 to 30 milligrams of Vitb6, 1.8 to 3.2 grams of glutathione, and 3 to 8 grams of Vit c. The injection enters human body by injecting, is directly absorbed, can effectively and lastingly activate the functions of ovarian cells, repair special nutritional substances of atrophic ovary, promote female hormone balance, improve climacteric symptoms and particularly improve secretion of female hormone and progestogen, and has a remarkable curative effect; the injection is used for comprehensively conditioning various symptoms caused by female endocrine dyscrasia, and has remarkable effects of improving the immunity of the body, preventing osteoporosis and quickly eliminating the symptoms such as hot flash, hidrosis, insomnia, dysphoria, waist soreness, backache, menstrual disorder, skin stain and lumbar and abdominal obesity; and the injection avoids risks and potential safety hazards caused by estradiol in conventional therapy.
Owner:东莞市光华生物科技有限公司

Kit for specifically detecting abdominal obesity through detecting rs12409479

The invention discloses a kit for specifically detecting abdominal obesity through detecting rs12409479. The kit comprises a specific primer pair and a specific fluorescent probe pair which are used for detecting a No. rs12409479 SNP (Single Nucleotide Polymorphism) site, a conventional assembly for carrying out fluorescent quantitative PCR (Polymerase Chain Reaction) detection and the like. The kit disclosed by the invention is used for evaluating the hereditary susceptibility of the abdominal obesity of individuals through detecting a single nucleotide polymorphism site gene type on the rs12409479 which is tightly related to the hereditary susceptibility of the abdominal obesity at the same time.
Owner:刘露

Synergistic herbal compositions for testosterone boosting

Synergistic herbal compositions comprising combination of a first ingredient selected from the extract(s), fraction(s), active compound(s) and phytochemicals or mixtures thereof derived from the plant parts of Punica granatum and a second ingredient selected from the extract(s), fraction(s), active compound(s) and phytochemicals or mixtures thereof derived from the plant parts of Theobroma cacao for improving testosterone levels. The invention further provides the method of obtaining at least one health benefit related to enhanced anabolic and androgenic activities in the body selected from improving testosterone levels, energy levels, sustained energy, vigor, stamina, healthy aging, cellular longevity, muscle mass, muscle strength sexual function (libido and erectile function) and psychological well-being (mood and focus); and reducing stress in humans and alleviating the symptoms associated with the low levels of testosterone in humans such as loss of libido, loss of erectile function, abdominal obesity, decreased muscle mass and strength, fatigue, mood swing, decreased bone density, decreased motivation, and decreased memory and concentration.
Owner:LAILA NUTRACEUTICALS

Mitochondrial modulation to improve metabolic syndrome during aging

Compounds, compositions and methods are provided for mitochondrial modulation. The subject mitochondrial modulator compounds generally include a head group linked to a charged moiety. In certain cases, the head group is a heterocyclic or a heteroaryl group. Aspects of the subject methods include a method of modulating mitochondria. Aspects of the subject methods include treating a subject having a metabolic syndrome-related disease or a symptom thereof by administering to the subject a therapeutically effective amount of a subject compound. In certain cases, the disease is selected from hyperlipidemia, type 2 diabetes, fatty liver disease, obesity, cardiovascular disease and stroke. In certain cases, the symptom is selected from abdominal obesity, insulin resistance, hyperinsulinemia, high levels of blood fats, increased blood pressure, and elevated serum lipids.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV

A pharmaceutical composition for weight loss, including its preparation and its preparation method

The invention relates to a weight losing medicine composition, a preparation containing the medicine composition and a preparation method of the medicine composition, belonging to the technical field of medicines. The weight losing medicine composition comprises the following active ingredients: Indian buead, largehead atractylodes rhizome, pinellia tuber, immature bitter orange, fortune eupatorium herb, rhizoma atractylodis, officinal magnolia bark, rhubarb, radix bupleuri, katsumade galangal seed, lotus leaf, combined spicebush root, cassia bark, safflower, Chinese angelica, white paeony root, Szechuan lovage rhizome, pericarpium zanthoxyli, radix astragali, oriental waterplantain rhizome, villous amomum fruit and capsaicine. A new way is provided for treating obesity, especially abdominal obesity. The weight losing medicine composition and the preparation containing the medicine composition can be used for resolving turbidity and eliminating fullness and preventing and treating complications of obesity, especially abdominal obesity by improving fat metabolism and have the effect of obviously improving abdominal fat accumulation. In particular, the smearing preparation can be locally used and combines with cupping therapy to promote medicine absorption and prolong the duration of the curative effects, and can be used for clinically preventing and treating abdominal obesity and complications thereof.
Owner:DONGFANG HOSPITAL BEIJING UNIV OF CHINESE MEDICINE

Copepod oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders

This invention relates to an oil composition, preferably obtained from a copepod, and the use thereof to reduce accumulation of visceral fat and counteract impairment of heart function caused by obesity inducing Western diets. The oil composition of the present invention can thus be used to reduce abdominal obesity and improve glucose tolerance and thus to reduce the risk of obesity related diseases such as but not limited to type 2 diabetes or cardiovascular disease, or to prevent or treat such diseases.
Owner:CALANUS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products